The influence of rifampicin discontinuation on rifampicin-induced cytochrome P450 enzyme activity
Not Applicable
- Conditions
- Mycobacterial infection
- Registration Number
- JPRN-UMIN000004083
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criterias are as follows. :Drug hypersensitivity (particularly to agents included in the studies) :Taking any medication :History of alcohol or drug abuse :History or presence of liver dysfunction :History or presence of tuberculosis :Participation in a clinical trial during the last 6 months prior to the start of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess pharmacokinetics of CYP substrate drugs with or without rifampicin.
- Secondary Outcome Measures
Name Time Method